U.S. flag

An official website of the United States government

NM_001458.5(FLNC):c.6120C>T (p.Asp2040=) AND not provided

Germline classification:
Benign (2 submissions)
Last evaluated:
Apr 9, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000711692.7

Allele description [Variation Report for NM_001458.5(FLNC):c.6120C>T (p.Asp2040=)]

NM_001458.5(FLNC):c.6120C>T (p.Asp2040=)

Genes:
FLNC-AS1:FLNC antisense RNA 1 [Gene - HGNC]
FLNC:filamin C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q32.1
Genomic location:
Preferred name:
NM_001458.5(FLNC):c.6120C>T (p.Asp2040=)
HGVS:
  • NC_000007.14:g.128852943C>T
  • NG_011807.1:g.27515C>T
  • NM_001127487.2:c.6021C>T
  • NM_001458.5:c.6120C>TMANE SELECT
  • NP_001120959.1:p.Asp2007=
  • NP_001449.3:p.Asp2040=
  • NP_001449.3:p.Asp2040=
  • LRG_870t1:c.6120C>T
  • LRG_870:g.27515C>T
  • LRG_870p1:p.Asp2040=
  • NC_000007.13:g.128492997C>T
  • NM_001458.4:c.6120C>T
Links:
dbSNP: rs116974302
NCBI 1000 Genomes Browser:
rs116974302
Molecular consequence:
  • NM_001127487.2:c.6021C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001458.5:c.6120C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000842079Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Benign
(Apr 9, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001979413Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Likely benigngermlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]
PMID:
26467025
PMCID:
PMC4737317

Details of each submission

From Athena Diagnostics, SCV000842079.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ - VKGL Data-share Consensus, SCV001979413.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024